Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
398 INR | +1.53% | -6.33% | -1.81% |
04-30 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
04-15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.81% | 1.14B | |
+31.18% | 695B | |
+26.51% | 568B | |
-4.62% | 361B | |
+19.71% | 330B | |
+3.87% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.96% | 168B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit